![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-19-2024-84054.pdf
https://www.globenewswire.com/news-release/2024/05/30/2890680/0/en/Pacira-BioSciences-to-Participate-in-Fireside-Chat-at-the-2024-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/10/2879551/0/en/Pacira-BioSciences-Inc-Announces-Pricing-of-250-0-Million-Aggregate-Principal-Amount-of-2-125-Convertible-Senior-Notes-due-2029.html
https://www.globenewswire.com/news-release/2024/05/08/2878229/0/en/Pacira-BioSciences-Inc-Announces-Proposed-Offering-of-250-0-Million-Aggregate-Principal-Amount-of-Convertible-Senior-Notes.html
https://www.globenewswire.com/news-release/2024/05/07/2877172/0/en/Pacira-BioSciences-Reports-First-Quarter-2024-Financial-Results-and-Announces-150-Million-Share-Repurchase-program.html
https://www.globenewswire.com/news-release/2024/05/07/2876659/0/en/Pacira-BioSciences-to-Participate-in-Fireside-Chat-at-the-2024-RBC-Capital-Markets-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/04/30/2872152/0/en/Pacira-to-Report-First-Quarter-2024-Financial-Results-on-Tuesday-May-7-2024.html
https://www.globenewswire.com/news-release/2024/04/02/2855915/0/en/Pacira-BioSciences-to-Participate-in-Fireside-Chat-at-the-23rd-Annual-Needham-Virtual-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/03/13/2845287/0/en/Pacira-BioSciences-Announces-PCRX-201-Granted-Regenerative-Medicine-Advance-Therapy-RMAT-Designation-for-the-Treatment-of-Osteoarthritis-of-the-Knee.html
https://www.globenewswire.com//news-release/2024/03/06/2841365/0/en/Pacira-BioSciences-to-Participate-in-Fireside-Chat-at-the-Barclays-26th-Annual-Global-Healthcare-Conference.html